References
1. P G, J V, L Z, C T, S A. Antigen presentation and T cell stimulation
by dendritic cells. Annual review of immunology 2002; 20:621-67.
2. Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K,
Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic
human dendritic cells. Front Immunol 2013; 4:82.
3. De
Sousa C P, CM B, EP S, AM C, RA K. Murine mammary carcinoma cells and
CD11c(+) dendritic cells elicit distinct responses to lipopolysaccharide
and exhibit differential expression of genes required for TLR4
signaling. Cellular immunology 2010; 266:67-75.
4. M L, W D, X Z, H H, A N, JR G. Therapeutic induction of tolerance by
IL-10-differentiated dendritic cells in a mouse model of house dust
mite-asthma. Allergy 2011; 66:612-20.
5. F Z, B C, GX Z, A R. Immunotherapy using
lipopolysaccharide-stimulated bone marrow-derived dendritic cells to
treat experimental autoimmune encephalomyelitis. Clinical and
experimental immunology 2014; 178:447-58.
6. F
Z, GX Z, A R. LPS-treated bone marrow-derived dendritic cells induce
immune tolerance through modulating differentiation of CD4 regulatory T
cell subpopulations mediated by 3G11 and CD127. Immunologic research
2017; 65:630-8.
7. de Aragao-Franca LS, Aragao-Franca LS, Rocha V, Rocha V,
Cronemberger-Andrade A, Da CF, et al. Tolerogenic Dendritic Cells Reduce
Airway Inflammation in a Model of Dust Mite Triggered Allergic
Inflammation. Allergy Asthma Immunol Res 2018; 10:406-19.
8. U S, P R. Tolerogenic dendritic cells: molecular and cellular
mechanisms in transplantation. Journal of leukocyte biology 2014;
95:53-69.
9. Bol
KF, Schreibelt G, Gerritsen WR, de Vries IJ, Figdor CG. Dendritic
Cell-Based Immunotherapy: State of the Art and Beyond. Clin Cancer Res
2016; 22:1897-906.
10. Yoo S, Ha SJ. Generation of Tolerogenic Dendritic Cells and Their
Therapeutic Applications. Immune Netw 2016; 16:52-60.
11. MA B, JR K, MS H, JJ Z, van Ham SM, A TB. IL-10-generated
tolerogenic dendritic cells are optimal for functional regulatory T cell
induction–a comparative study of human clinical-applicable DC.
Clinical immunology (Orlando, Fla.) 2012; 142:332-42.
12. M
L, W D, X Z, H H, A N, JR G. Therapeutic induction of tolerance by
IL-10-differentiated dendritic cells in a mouse model of house dust
mite-asthma. Allergy 2011; 66:612-20.
13. Huang H, Dawicki W, Lu M, Nayyar A, Zhang X, Gordon JR. Regulatory
dendritic cell expression of MHCII and IL-10 are jointly requisite for
induction of tolerance in a murine model of OVA-asthma. Allergy 2013;
68:1126-35.
14. T
K, H M, K T, S M, N M, A B, et al. IL-10-treated dendritic cells
decrease airway hyperresponsiveness and airway inflammation in mice. The
Journal of allergy and clinical immunology 2007; 119:1241-50.
15. De
Smedt T, Van Mechelen M, De Becker G, J U, O L, M M. Effect of
interleukin-10 on dendritic cell maturation and function. European
journal of immunology 1997; 27:1229-35.
16. S F, N Y, Y I, Y S, K S, K E, et al. Regulatory dendritic cells
protect against allergic airway inflammation in a murine asthmatic
model. The Journal of allergy and clinical immunology 2008; 121:95-104.
17. R K, J W, JR O, G J, J Z, KA S, et al. Uptake of apoptotic DC
converts immature DC into tolerogenic DC that induce differentiation of
Foxp3+ Treg. European journal of immunology 2010; 40:1022-35.
18. YG K, CH S, HK Y, PH H, JS K, KS L, et al. Involvement of PTEN in
airway hyperresponsiveness and inflammation in bronchial asthma. The
Journal of clinical investigation 2003; 111:1083-92.
19. F F, D F, A S, S R, L R, A M, et al. Reduced tumorigenicity and
augmented leukocyte infiltration after monocyte chemotactic protein-3
(MCP-3) gene transfer: perivascular accumulation of dendritic cells in
peritumoral tissue and neutrophil recruitment within the tumor. Journal
of immunology (Baltimore, Md. : 1950) 1998; 161:342-6.
20. J B, RM S. Dendritic cells and the control of immunity. Nature 1998;
392:245-52.
21. AS A, RR H, F A, KA A. Changing survival, memory cell compartment,
and T-helper balance of lymphocytes between severe and mild asthma. BMC
immunology 2008; 9:73.
22. M P, MK J. Origins of CD4(+) effector and central memory T cells.
Nature immunology 2011; 12:467-71.
23. F S, J G, A L. Central memory and effector memory T cell subsets:
function, generation, and maintenance. Annual review of immunology 2004;
22:745-63.
24. H H, W D, X Z, J T, JR G. Tolerogenic dendritic cells induce
CD4+CD25hiFoxp3+ regulatory T cell differentiation from
CD4+CD25-/loFoxp3- effector T cells. Journal of immunology (Baltimore,
Md. : 1950) 2010; 185:5003-10.
25. SS A. Targeting cell signaling in allergic asthma. Signal
transduction and targeted therapy 2019; 4:45.
26.
Chen
Z, Wang S, Erekosima N, Li Y, Hong J, Qi X, et al. IL-4 confers
resistance to IL-27-mediated suppression on CD4+ T cells by impairing
signal transducer and activator of transcription 1 signaling. J Allergy
Clin Immunol 2013; 132:912-21.
27. K S, M W, H J, J K, AH E. Pillars Article: Induction of Tolerance by
IL-10-Treated Dendritic Cells. J. Immunol. 1997. 159: 4772-4780. Journal
of immunology (Baltimore, Md. : 1950) 2016; 197:1547-55.
28. KK E, S T, F N, KG W, VW Y, QJ P, et al. Early life exposure to
lipopolysaccharide suppresses experimental autoimmune encephalomyelitis
by promoting tolerogenic dendritic cells and regulatory T cells. Journal
of immunology (Baltimore, Md. : 1950) 2009; 183:298-309.
29. Nayyar A, Dawicki W, Huang H, Lu M, Zhang X, Gordon JR. Induction of
prolonged asthma tolerance by IL-10-differentiated dendritic cells:
differential impact on airway hyperresponsiveness and the Th2
immunoinflammatory response. J Immunol 2012; 189:72-9.
30. D Z, Q C, VW L, Y W, G Z, Y W, et al. Lipopolysaccharide-pretreated
plasmacytoid dendritic cells ameliorate experimental chronic kidney
disease. Kidney international 2012; 81:892-902.
31. B
A, T F, RD R, AM D, D Q, A H, et al. Lipopolysaccharide stimulation of
dendritic cells induces interleukin-10 producing allergen-specific T
cells in vitro but fails to prevent allergic airway disease.
Experimental lung research 2009; 35:307-23.
32. I
B, S S, B K, AB R, J K, J S. Interleukin-10-treated dendritic cells do
not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
International archives of allergy and immunology 2006; 141:61-9.
33. X
L, A Y, H H, X Z, J T, B D, et al. Induction of type 2 T helper cell
allergen tolerance by IL-10-differentiated regulatory dendritic cells.
American journal of respiratory cell and molecular biology 2010;
42:190-9.
34. AE
A, DJ S, BL S, RA H, AM P, von Delwig A, et al. LPS activation is
required for migratory activity and antigen presentation by tolerogenic
dendritic cells. Journal of leukocyte biology 2009; 85:243-50.
35. SJ B, WJ M, CA W, MI G. A role for Th2 T-memory cells in early
airway obstruction. Cellular immunology 1996; 170:185-94.
36. JR
L, DL F. Generation, persistence and plasticity of CD4 T-cell memories.
Immunology 2010; 130:463-70.
37. M
L, W D, X Z, H H, A N, JR G. Therapeutic induction of tolerance by
IL-10-differentiated dendritic cells in a mouse model of house dust
mite-asthma. Allergy 2011; 66:612-20.
38. S M, T M, T K, Y N, K K, K T, et al. STAT6 deficiency in a mouse
model of allergen-induced airways inflammation abolishes eosinophilia
but induces infiltration of CD8+ T cells. Clinical and experimental
allergy : journal of the British Society for Allergy and Clinical
Immunology 1999; 29:114-23.
39. DH
S, PA S, GR Z, LS S, JA T, DJ T, et al. Reversal of airway
hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory
T cells. The Journal of experimental medicine 2006; 203:2649-60.
40. BD M, E S, S H, SY T, BP S, JS D, et al. CD11b+ myeloid cells are
the key mediators of Th2 cell homing into the airway in allergic
inflammation. Journal of immunology (Baltimore, Md. : 1950) 2009;
182:623-35.